Herzog & de Meuron's AstraZeneca HQ hit by further delays

Herzog & de Meuron's AstraZeneca headquarters in Cambridge

Completion put back to 2020 as cost spirals

 Further delays to the construction of pharmaceutical giant AstraZeneca’s new headquarters in Cambridge could push the building’s final price tag to more than £500m.

Completion of the Herzog & de Meuron-designed project is now expected in the first half of 2020, nearly three years behind schedule.

AstraZeneca, which develops treatments for heart disease, cancer and respiratory illnesses, had expected to move into the building, located on the Cambridge Biomedical Campus, in the latter part of last year.


This content is available to Registered users

You are not currently logged in.

LOGIN or REGISTER to access this story

LOGIN or REGISTER for free access on selected stories and sign up for email alerts.

Take out a subscription to BD and you will get immediate access to:

  • Up to the minute architecture news from around the UK
  • Reviews of the latest buildings from all corners of the world
  • Our monthly digital edition including stunning photos, building and technical studies
  • Full access to all our online archives
  • PLUS you will receive a print copy of WA100 when it is published in January

Get access to premium content subscribe today